Cell Analysis Market Poised for Growth, with a Valuation of US$ 29.78 Billion Expected by 2030, at a CAGR of 9.98%

Name: Cell Analysis Market Growth Analysis Research Report by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech), and Regional Forecast till 2030
Creator: Market Report Service
Published: 2023-11-02
License: https://marketreportservice.com/privacy-policy

Cell Analysis Market Growth Analysis Research Report by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech), and Regional Forecast till 2030

5/5

( 27 votes )

Categories: Pharma & Healthcare

Format : Cell Analysis Market Poised for Growth, with a Valuation of US$ 29.78 Billion Expected by 2030, at a CAGR of 9.98%

Request Sample

Summary TOC Segmentation Methodology Infographics

Cell Analysis Market Snapshot

“The Cell Analysis Market is estimated to increase at a CAGR 9.98% from $ 15.63 Billion in 2023 to $ 29.78 Billion by 2030.”

Cell analysis evaluates and measures cell number, condition, viability, health, proliferation, and toxicity through chemicals and cells. It provides insights in basic research, drug development, and therapeutic applications, using various methods and tests.

Cell analysis is crucial in drug research and discovery, aiding in understanding drug candidates' efficacy, toxicity, moA, and formulation. In vitro preclinical studies use various cell analysis techniques, enabling informed decision-making for development and advancing promising candidates to in vivo preclinical and clinical studies.

These sophisticated cell analysis approaches enhance the effectiveness and success of drug development initiatives.

Single-cell analysis and subcellular analysis are methods used in cellular biology to study genomes, transcriptomics, proteomics, metabolomics, and cell-cell interactions at the single cell level. The concept was first introduced in the 1970s and was initially used to analyze or manipulate a single cell within a large population under specific conditions.

Becton Dickinson Holdings Pte. Ltd. announced in March 2023 that it will continue its research collaboration with the Agency for Science, Technology, and Research. The partnership will use advanced technology, such as the BD FACSymphony A5 SE Cell Analyzer unit, to apply spectral flow cytometry panels for deep immunophenotyping of human tissues, aiming to improve healthcare outcomes.

Cell Analysis Market | Market Report Service

>>>Download Sample Report Now:https://marketreportservice.com/request-sample/cell-analysis-market-54668

Market Trends

The cell analysis market is thriving due to the integration of new and existing technologies, enabling researchers and medical professionals to create more precise instruments, leading to an increase in technology integration.

Deepcell, a company specializing in single cell analysis using artificial intelligence, introduced the REM-I Platform in May 2023. The platform, which includes benchtop devices, the Axon data suite, and the Human Foundation Model, enables single cell sorting, imaging, and analysis, potentially advancing research in developmental biology, stem cell biology, cancer biology, gene therapy, and functional screening.

Deepcell claims this AI-driven cellular analysis method will lead to new discoveries.

Growth Drivers

The use of cell-based screening assays in drug discovery has increased due to the vast amounts of data generated by developments in cell biology, bioinformatics, molecular biology, genomics, and proteomics.

The Human Genome Project has produced several targets for drug screening studies, and the creation of cell-based assays for primary and secondary screening in drug discovery has accelerated in recent years due to the rapid growth of therapeutic targets and drug leads.

Restraints

High-throughput screening and high-content screening technologies have improved cell analysis reliability, but their increased instrument prices have also led to increased reagent usage limitations.

The complexity of target molecules directly impacts the time and cost of each HTS procedure, making it more expensive for more complex molecules. This has resulted in a significant increase in the overall cost of biopharmaceutical manufacturing in biopharmaceutical businesses.

Cell Analysis Market Segment Analysis

Flow cytometry is a method that analyzes single cells using lasers, examining them using fluorescence or visible light scattering. It can be obtained without light scatter analysis by producing and transfecting fluorescent proteins like GFP and labeling them with antibodies or dyes. Flow cytometry is commonly used in immunology, cancer biology, and disease research in molecular and cellular biology.

The global cell analysis market is divided into segments like reagents and consumables, instruments, accessories, software, and services. In 2022, the reagents & consumables sector held the most market share, with flow cytometry reagents offered by well-known vendors.

The segment's growth is driven by innovative services that handle complex information with multiple analytical modalities for optimal interpretation.

Modern genetics, molecular and cellular biology research, and other vital fields rely on the ability to analyze DNA, RNA, and proteins. Our genomic resources provide researchers with tools and technology to advance their work, including advanced gene editing, gene expression, silencing, PCR, and qPCR. Explore our range of resources for dependable protocols, reagents, and technical knowledge.

Protein mass spectrometry is widely used in proteomics studies, biomarker development, and therapeutic applications due to its ability to perform complex analysis and its superiority over other methods for large-scale protein characterisation.

Mass spectrometry is a method used to quantitatively identify and describe proteins, considering their relationships, structure, and post-translational modifications.

Competitive Landscape of the Cell Analysis Market Analysis

Danaher (US)
Thermo Fisher Scientific (US)
Becton
Dickinson and Company (US)
General Electric (US)
Merck KGaA (US)
Agilent Technologies (US)
Olympus Corporation (Japan)
Miltenyi Biotec (US)
Bio-Rad Laboratories (US)
BioStatus Limited (UK)
Fluidigm Corporation (US)
NanoCellect Biomedical (US)
Cell Biolabs (US)
Creative Bioarray (US)
Meiji Techno (US)
Promega Corporation (US)
PerkinElmer (US)
Tecan Trading AG (Switzerland)
CELLINK (US)
QIAGEN (Germany)
Corning Incorporated (US)
10x Genomics (US)
and Illumina (US).

New Developments in Cell Analysis Market

In January 2023, Axion BioSystems expanded its Omni live-cell imaging product family with the introduction of the Omni Pro 12 platform. The new platform is equipped with integrated robotics and a multiplate design compatible with any standard incubator, providing scientists and drug developers with increased flexibility and efficiency for live-cell imaging experiments. The platform offers a valuable tool in advancing research in areas such as oncology, immunology, and stem cell biology. The technology has the potential to facilitate the development of novel drugs and therapeutics.

2023-09-28-Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.â€¯

In 2023, Becton, Dickinson and Company (US) launched a Spectral Cell Sorter that is coupled with high-speed cell imaging. this product combines real-time imaging technology with spectral flow cytometry.

Regional Analysis of Global Cell Analysis Industry

How Has North America Influenced the Market for Cell Analysis?

The cell analysis technique identifies subpopulations of mesenchymal stromal cells that exhibit in vitro immunosuppressive activity.

The FDA has developed a method to improve the recognition of specific cell batches for human treatments. Growth factors, which are molecules that mesenchymal stromal cells (MSCs) react to, can help MSCs differentiate into bone, fat, or cartilage-forming cells.

This process aids in tissue regeneration and restoration. Growth factors also stimulate MSCs, reducing immune cell activity and regulating inflammation. This could be beneficial for immune system diseases like multiple sclerosis and Crohn's disease, which can benefit from immune suppression.

The Single Cell Analysis USA congress explores data management, informatics, epigenomic DNA and RNA sequencing, and single cell genomics in cancer research. Topics include cancer stem cells and immunotherapy, cutting-edge single-cell separation, processing, imaging, and cytometry. The congress also covers therapeutic targeting in clinics and translational medicine.

Segments Covered in the Cell Analysis Market Report

Segment by Product and Services

Reagents & Consumables
Instruments
Accessories
Software
Service

Segment by Technique

Flow Cytometry
PCR
Cell Microarrays
Microscopy
Spectrophotometry
High Content Screening
Other Techniques

By Process

Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Cell Structure Study
Target Identification and Validation
Single-Cell Analysis

By End User

Pharmaceutical & Biotechnology Companies
Hospitals and Clinical Testing Laboratories
Academic and Research Institutes
Other End Users

Market by Region

North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America

Frequently Asked Questions

What is the meaning of Cell Analysis?

Cell analysis is used to evaluate and measure cell number, cell state, cell health and viability, proliferation, and chemical and cell-mediated toxicity.

What are some applications of Cell Analysis?

Cultured animal cells can introduce new genetic material like DNA or RNA, allowing for the study of gene expression and cell health, while insect cells are used to produce commercially important proteins by infecting them with genetically altered baculoviruses.

What is the expected growth rate of the Cell Analysis market over the next 7 years?

The Cell Analysis Market is estimated to increase at a CAGR 9.98% from $ 15.63 Billion in 2023 to $ 29.78 Billion by 2030.

Who are the major players in the Cell Analysis market and what is their market share?

Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US), are prominent players operating and dominating in the market.

Who are the top 3 Cell Analysis Market Key Vendors?

Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), are key players in the Cell Analysis market.

Which geographical areas dominate the worldwide market for Cell Analysis?

North America region are emerging as the top regional markets for Cell Analysis solutions.

SUMMARY

1.1. Cell Analysis Market Overview

1.2. Key Insights

1.3. Report Scope

1.4. Research Methodology

1.5. Frequently Asked Questions

1.6. Chapter Outlines

DECISION-MAKING SUMMARY
INTRODUCTION

3.1. Overview of Cell Analysis

3.2. Key Historical Events

3.3. Structure

3.4. Biochemical Interaction

3.5. Target Indications

3.6. Advantages of Cell Analysis

3.7 Challenges associated with Cell Analysis

3.8. Future Perspectives.

MARKET LANDSCAPE

4.1. Methodology

4.2 Cell Analysis: Developer Landscape

4.2.1. Analysis by Year of Establishment

4.2.2. Analysis by Company Size

4.2.3. Analysis by Location of Headquarters (Region-wise)

4.2.4. Analysis by Location of Headquarters (Country-wise)

4.2.5. Analysis by Year of Establishment, Company Size and Location of Headquarters (Region-wise)

4.2.6. Most Active Players

COMPANY

5.1. Company Overview

5.1.2 Management Team

5.1.3. Product Portfolio

5.1.4. Recent Developments and Future Outlook

PARTNERSHIPS AND COLLABORATIONS

6.1. Partnership Models

6.2. Cell Analysis: Partnerships and Collaborations

6.2.1. Analysis by Year of Partnership

6.2.2. Analysis by Type of Partnership

6.2.3. Analysis by Year and Type of Partnership

6.2.4. Analysis by Type of Partner

6.2.5. Analysis by Year of Partnership and Type of Partner

6.2.6. Analysis by Type of Partnership and Type of Partner

6.2.7. Analysis by Type of Partner and Parent Company Size

ACADEMIC GRANTS ANALYSIS

7.1. Methodology and Key Parameters

7.2. Cell Analysis: Academic Grants Analysis

7.2.1. Analysis by Year of Grant Award

7.2.2. Analysis by Amount Awarded

7.2.3. Analysis by Funding Institute Center

7.2.4. Analysis by Support Period

7.2.5. Analysis by Funding Institute Center and Support Period

7.2.6. Analysis by Type of Grant Application

7.2.7. Analysis by Purpose of Grant

PUBLICATION ANALYSIS

8.1. Analysis Methodology and Key Parameters

8.2. Cell Analysis: Publication Analysis

8.2.1. Analysis by Year of Publication

8.2.2. Analysis by Type of Publication

8.2.3. Analysis by Type of Conjugate

8.2.4. Analysis by Target Indication

8.2.5. Analysis by Copyright Holder

8.2.6. Word Cloud: Emerging Focus Area

8.2.7. Most Active Publishers: Analysis by Number of Publications

SUCCESS PROTOCOL ANALYSIS

9.1. Methodology and Key Parameters

9.2. Key Assumptions and Scoring Criteria

9.3. Success Protocol Analysis

9.4. Assessment of Approved Cell Analysis

Appendix 1: Tabulated Data
Appendix 2: List of Companies

Danaher (US)
Thermo Fisher Scientific (US)
Becton
Dickinson and Company (US)
General Electric (US)
Merck KGaA (US)
Agilent Technologies (US)
Olympus Corporation (Japan)
Miltenyi Biotec (US)
Bio-Rad Laboratories (US)
BioStatus Limited (UK)
Fluidigm Corporation (US)
NanoCellect Biomedical (US)
Cell Biolabs (US)
Creative Bioarray (US)
Meiji Techno (US)
Promega Corporation (US)
PerkinElmer (US)
Tecan Trading AG (Switzerland)
CELLINK (US)
QIAGEN (Germany)
Corning Incorporated (US)
10x Genomics (US)
Illumina (US).